{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:43:15Z","timestamp":1792424595214,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Department of Health and Social Care"},{"name":"Fleming Fund","award":["R52354 CN001"],"award-info":[{"award-number":["R52354 CN001"]}]},{"name":"UK National Institute for Health and Care Research","award":["NIHR305136"],"award-info":[{"award-number":["NIHR305136"]}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR HealthTech Research Centre"},{"name":"In Vitro Diagnostics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This paper examines the Fleming Fund as a major long-term investment in strengthening antimicrobial resistance (AMR) surveillance in low- and middle-income countries. Established by the UK Department of Health and Social Care in 2015, the Fund committed up to \u00a3498 million to support surveillance capacity across 25 countries in Africa and Asia through a One Health approach spanning human, animal and environmental health. The paper situates the Fleming Fund within wider global concern about AMR and highlights surveillance as essential for stewardship, policy and international coordination. It describes the Fleming Fund's design logic, governance arrangements, grant architecture and evolving strategic priorities, with particular attention to how the program combined laboratory strengthening, workforce development, data systems, quality assurance, sampling pathways and multisectoral coordination to generate credible and usable AMR data. The analysis also examines the Phase 2 shift from an initial emphasis on data generation toward greater attention to data interpretation, dissemination and use in policy and practice. Drawing on program documentation, evaluation evidence and stakeholder perspectives, the paper presents the Fleming Fund as an important case of large-scale surveillance system strengthening in resource-constrained settings. It argues that the Fund offers wider lessons on the time, coordination and institutional embedding required to move from externally supported capacity building toward sustainable national surveillance functions. These lessons are relevant to future AMR investments and to broader debates on global health security, health systems strengthening and One Health implementation.<\/jats:p>","DOI":"10.1093\/cid\/ciag499","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:29:50Z","timestamp":1792423790000},"page":"S3-S12","source":"Crossref","is-referenced-by-count":0,"title":["The Fleming Fund: Key Features of Design and Approach to Strengthening Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0792-660X","authenticated-orcid":false,"given":"Tim","family":"Shorten","sequence":"first","affiliation":[{"name":"Itad Ltd , Brighton ,","place":["United Kingdom"]},{"name":"Independent Consultant, Redgrave ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemima","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Health and Social Care, London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archibald","family":"Drake","sequence":"additional","affiliation":[{"name":"Itad Ltd , Brighton ,","place":["United Kingdom"]},{"name":"Independent Consultant , Dar es Salaam ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5150-2970","authenticated-orcid":false,"given":"Ankur","family":"Gupta-Wright","sequence":"additional","affiliation":[{"name":"Itad Ltd , Brighton ,","place":["United Kingdom"]},{"name":"Independent Consultant , Bristol ,","place":["United Kingdom"]},{"name":"Department of Infectious Disease, Imperial College , London ,","place":["United Kingdom"]},{"name":"Department of Infectious Diseases and Tropical Medicine, University of Heidelberg , Heidelberg ,","place":["Germany"]},{"name":"Department of Infectious Diseases, Bristol NHS Foundation Trust , Bristol ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-9346","authenticated-orcid":false,"given":"Milena","family":"von und zur M\u00fchlen","sequence":"additional","affiliation":[{"name":"Department of Health and Social Care , Leeds ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1467-3631","authenticated-orcid":false,"given":"Evelyn","family":"Wesangula","sequence":"additional","affiliation":[{"name":"Itad Ltd , Brighton ,","place":["United Kingdom"]},{"name":"Independent Consultant , Arusha ,","place":["Tanzania"]},{"name":"East Central and Southern Africa Health Community , Arusha ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"2026101911294282100_ciag499-B1","article-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"O\u2019Neill","year":"2016","journal-title":"Rev Antimicrob Resis"},{"key":"2026101911294282100_ciag499-B2","volume-title":"Global antibiotic resistance surveillance report 2025: WHO global antimicrobial resistance and use surveillance system (GLASS)","author":"World Health Organization","year":"2024"},{"key":"2026101911294282100_ciag499-B3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2026101911294282100_ciag499-B4","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/cid\/ciag497","article-title":"Generating actionable data from Antimicrobial Resistance Surveillance: insights from the Fleming Fund's international experience","volume":"83","author":"Gupta-Wright","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294282100_ciag499-B5","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/ciag520","article-title":"Surveillance data use through the Fleming Fund: informing action on Antimicrobial Resistance in low- and middle-income countries","volume":"83","author":"Drake","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294282100_ciag499-B6","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/cid\/ciag517","article-title":"Antimicrobial resistance and one health: lessons on one health governance and implementation from the Fleming fund","volume":"83","author":"Abbas","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294282100_ciag499-B7","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/cid\/ciag500","article-title":"Fleming Fund implementation in Kenya: what have we learned about strengthening one health Antimicrobial Resistance Surveillance for decision-making?","volume":"83","author":"Wesangula","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294282100_ciag499-B8","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/cid\/ciag498","article-title":"Reflections for the future of AMR Surveillance and AMR action","volume":"83","author":"Chandler","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911294282100_ciag499-B9","author":"Fleming Fund"},{"key":"2026101911294282100_ciag499-B10","author":"World Health Organization"},{"key":"2026101911294282100_ciag499-B11","author":"Food and Agriculture Organization of the United Nations"},{"key":"2026101911294282100_ciag499-B12","author":"World Organisation for Animal Health"},{"key":"2026101911294282100_ciag499-B13","author":"United Nations Environment Programme"},{"key":"2026101911294282100_ciag499-B14","author":"South Centre"},{"key":"2026101911294282100_ciag499-B15","author":"Commonwealth Pharmacists Association"},{"key":"2026101911294282100_ciag499-B16","author":"FIND"},{"key":"2026101911294282100_ciag499-B17","author":"Oxford University Clinical Research Unit"},{"key":"2026101911294282100_ciag499-B18","author":"World Health Organization"},{"key":"2026101911294282100_ciag499-B19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.12688\/wellcomeopenres.12527.1","article-title":"AMR surveillance in low and middle-income settings\u2014a roadmap for participation in the global antimicrobial surveillance system (GLASS)","volume":"2","author":"Seale","year":"2017","journal-title":"Wellcome Open Res"},{"key":"2026101911294282100_ciag499-B20"},{"key":"2026101911294282100_ciag499-B21","volume-title":"The international FAO antimicrobial resistance monitoring (InFARM) system\u2014manual for implementation 2024","author":"Food and Agriculture Organization","year":"2024"},{"key":"2026101911294282100_ciag499-B22","author":"ANIMUSE"},{"key":"2026101911294282100_ciag499-B23","volume-title":"Fleming fund programme principles and strategic shifts","author":"Department of Health and Social Care","year":"2023"},{"key":"2026101911294282100_ciag499-B24","volume-title":"Independent evaluation of the fleming fund grants programme; volume 1: summative report","author":"Fleming Fund","year":"2023"},{"key":"2026101911294282100_ciag499-B25","volume-title":"Independent summative evaluation of the fleming fund, 2017\u20132026","author":"Itad","year":"2026"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/Supplement_1\/S3\/72114898\/ciag499.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/Supplement_1\/S3\/72114898\/ciag499.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:30:03Z","timestamp":1792423803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/Supplement_1\/S3\/8943556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":25,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,10,19]]},"published-print":{"date-parts":[[2026,10,19]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag499","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,10,15]]}}}